Plain-English Summary
Protein leverage hypothesis in Nutrition researchers evaluating protein appetite and obesity models. Protein leverage is a useful model for understanding appetite pressure.
VV Study Evidence Matrix v1.0
VV Evidence Utility Score
A bounded score for how useful this study is in public explanation, based on evidence tier, design, applicability, endpoint relevance, limitations, safety signals, and publication/source strength.
65/100
Limited Public Evidence
- Evidence tier
- 66/100, weight 18%
- Design strength
- 60/100, weight 18%
- Applicability
- 70/100, weight 16%
- Endpoint relevance
- 58/100, weight 16%
- Limitations transparency
- 60/100, weight 12%
- Safety signal usefulness
- 57/100, weight 10%
- Publication/source strength
- 88/100, weight 10%
Useful for context, but limited by safety signal usefulness, endpoint relevance, design strength.
How the study framework works ->Key Findings
- Protein leverage is a useful model for understanding appetite pressure.
- It should not become protein tunnel vision.
Limitations
- Hypothesis/review source, not a direct product trial.
- Real diets involve fiber, texture, energy density, and food quality too.
Why It Matters
Protein appetite, energy dilution, and overeating risk.
Viral Vitalism Verdict
Useful evidence, bounded by design: Hypothesis/review source, not a direct product trial.
Sources
- Obesity: the protein leverage hypothesis - Obesity Reviews
Signal cards
Used in signals
Signal coverage connected to this study through explicit study links, canonical source refs, or evidence visualizations.
Ultra-Processed Foods and Protein Everything: Protein Halo or Processing Penalty?
Ultra-processed food debates are usually too crude. The useful question is which mechanisms drive harm: energy density, eating rate, texture, fiber, protein dilution, palatability, additives, food matrix, or processing itself. Protein can be protective, but protein-branded products can still be ultra-processed.
VV Signal Score
73
Promising signal
- Sources
- 8
- Studies
- 8
- Claims
- 5
Claim ledger
Relevant claims
Claim ledger records connected through this study's ID, topic tags, or source IDs.
weight loss: Sustained fat loss requires net energy deficit, but the
Sustained fat loss requires net energy deficit, but the appetite, expenditure, adaptation, and maintenance systems that shape that deficit are biologically regulated.
semaglutide: Semaglutide reduced major adverse cardiovascular events in SELECT participants
Semaglutide reduced major adverse cardiovascular events in SELECT participants with overweight or obesity and established cardiovascular disease without diabetes.
semaglutide: Semaglutide reduced body weight in adults with obesity or
Semaglutide reduced body weight in adults with obesity or overweight in randomized clinical-trial populations.
tirzepatide: Tirzepatide reduced body weight in adults with obesity or
Tirzepatide reduced body weight in adults with obesity or overweight in randomized clinical-trial populations.
glp 1: Semaglutide and tirzepatide produce clinically meaningful average weight loss
Semaglutide and tirzepatide produce clinically meaningful average weight loss in studied adults with obesity or overweight, with results and tolerability varying by drug, dose, and patient context.
tirzepatide: Tirzepatide improved obstructive sleep apnea outcomes in adults with
Tirzepatide improved obstructive sleep apnea outcomes in adults with obesity in SURMOUNT-OSA.